Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classical galactosaemia revisited.

Annet M Bosch1

  • 1Department of Pediatrics, Division of Metabolic Disorders, Academic Medical Centre (G8 205), University Hospital of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. a.m.bosch@amc.uva.nl

Journal of Inherited Metabolic Disease
|July 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of Riboflavin in Inherited Metabolic Diseases: A Systematic Review.

Journal of inherited metabolic disease·2026
Same author

Medicine Development and Access for Rare Diseases: Can We Do Better?

Journal of inherited metabolic disease·2026
Same author

Too Early to Tell? Balancing Diagnostic Accuracy of Newborn Screening for Propionic Acidemia Versus a Timely Referral.

International journal of neonatal screening·2026
Same author

Screening Tool Improves Recognition of Movement Disorders by Internists and Paediatricians in Patients With Inherited Metabolic Diseases.

Journal of inherited metabolic disease·2025
Same author

Reducing False Positives in Newborn Screening: The Role of Perinatal Factors in the Dutch NBS Program.

Metabolites·2025
Same author

Evaluation of Newborn Screening for Diseases Using C5-OH as a Marker: Systematic Review of the Literature and Evaluation of 17 Years of C5-OH Screening in the Netherlands.

Journal of inherited metabolic disease·2025

Classical galactosaemia, an autosomal recessive disorder, results from galactose-1-phosphate uridyltransferase (GALT) deficiency. Despite a galactose-restricted diet, long-term developmental and hormonal complications persist, necessitating novel therapeutic strategies.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Classical galactosaemia is an autosomal recessive metabolic disorder caused by galactose-1-phosphate uridyltransferase (GALT) deficiency.
  • Affected individuals often present neonatally with jaundice, hepatosplenomegaly, and hepatocellular insufficiency after galactose ingestion.

Purpose of the Study:

  • To summarize the diagnosis, current management, and persistent long-term complications of classical galactosaemia.
  • To highlight the need for novel therapeutic strategies beyond dietary restrictions.

Main Methods:

  • Diagnosis relies on measuring erythrocyte GALT activity.
  • Gas-chromatographic analysis of urinary sugars and sugar alcohols aids diagnosis by detecting elevated galactose and galactitol.

Related Experiment Videos

Main Results:

  • Despite a strict galactose-restricted diet, patients frequently experience developmental delays, motor abnormalities, and hypogonadism.
  • These long-term complications may stem from endogenous galactose production or abnormal galactosylation.

Conclusions:

  • Current therapy, a galactose-restricted diet, is insufficient to prevent significant long-term complications.
  • Future research should focus on developing therapies to prevent galactose-1-phosphate production.
  • Follow-up protocols must emphasize early detection and intervention for developmental issues in GALT-deficient patients.